<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia, Marie‐France Hamou, Nicolas de Tribolet, Michael Weller, Johan M. Kros, Johannes A. Hainfellner, Warren Mason, Luigi Mariani, Jacoline E. C. Bromberg, Peter Hau, R.O. Mirimanoff, J. Gregory Cairncross, Robert C. Janzer, Roger Stupp

New England Journal of Medicine, 2005

University Hospital of Lausanne, Molecular Oncology (United States), University of Lausanne, University Hospital of Geneva, University of Tübingen, Rotterdam University of Applied Sciences, Medical University of Vienna, Princess Margaret Hospital, University Hospital of Bern, University Medical Center Utrecht, University of Regensburg, University of Calgary

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

7170

Citations

View on Google Scholar

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Abstract

Journal Details

Join JournalsHub

Welcome Back